Zhu W D, Wang Z Y, Chai Y C, Wang X W, Chen D Y, Wu H
Department of Otolaryngology Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China; Ear Institute, Shanghai Jiaotong University, Shanghai, China; Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai, 200092, China.
Ear Institute, Shanghai Jiaotong University, Shanghai, China; Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai, 200092, China.
Eur J Med Genet. 2015 Sep;58(9):433-8. doi: 10.1016/j.ejmg.2015.05.008. Epub 2015 Jun 19.
The aim of this study was to assess the frequency of germline mutations and to explore genotype-phenotype associations in Chinese head and neck paraganglioma (HNPGL) patients without family history. Twenty-six Chinese patients with a diagnosis of HNPGL(14 male and 12 female, respectively)were recruited, who were followed up from 2000 to 2012. Genomic DNA was obtained from resected tumor tissues and peripheral blood samples. Seven genes, Succinate dehydrogenase complex A,B,C,D (SDHA, SDHB, SDHC, SDHD), succinate dehydrogenase complex assembly factor 2 (SDHAF2), TMEM127 (transmembrane protein 127) and VHL (Von Hippel-Lindau), were screened by direct sequencing and multiplex ligation-dependent probe amplification (MLPA) was performed to search for potential large deletions or duplications of SDHB, SDHC, SDHD, SDHAF1 and SDHAF2. The total frequency of germline mutations was 30.8% (8/26), including 5 cases with missense mutation p.Met1Ile in SDHD, 1 case with missense mutation p.Tyr216Cys in SDHB, and 1 case with a novel truncation mutation p.Gln44Ter in SDHAF2. MLPA showed one patient with malignant HNPGL had heterozygous deletions of exon1, 2, 3, 7 and 8 in SDHB. Mutations in SDHD were the leading cause of HNPGL in this study. Mutation carriers were younger than non-mutation carriers (p < 0.01) and more likely to suffer from multiple tumors (p = 0.048), especially with mutations in SDHD. The presence of mutation was associated with the development of larger tumors (p = 0.021). This study confirmed that the missense mutation p.Met1Ile at the start codon in SDHD was a hotspot in chinese patients with HNPGLs. We recommend genetic analysis in patients below 45 years, especially SDHD gene.
本研究旨在评估中国无家族史的头颈部副神经节瘤(HNPGL)患者种系突变的频率,并探索基因型与表型的关联。招募了26例诊断为HNPGL的中国患者(分别为14例男性和12例女性),他们在2000年至2012年期间接受随访。从切除的肿瘤组织和外周血样本中获取基因组DNA。通过直接测序筛选了7个基因,即琥珀酸脱氢酶复合物A、B、C、D(SDHA、SDHB、SDHC、SDHD)、琥珀酸脱氢酶复合物组装因子2(SDHAF2)、跨膜蛋白127(TMEM127)和VHL(冯·希佩尔-林道病)基因,并进行多重连接依赖探针扩增(MLPA)以寻找SDHB、SDHC、SDHD、SDHAF1和SDHAF2潜在的大片段缺失或重复。种系突变的总频率为30.8%(8/26),包括5例SDHD基因错义突变p.Met1Ile、1例SDHB基因错义突变p.Tyr216Cys和1例SDHAF2基因新的截短突变p.Gln44Ter。MLPA显示1例恶性HNPGL患者的SDHB基因外显子1、2、3、7和8存在杂合缺失。在本研究中,SDHD突变是HNPGL的主要原因。突变携带者比非突变携带者年轻(p<0.01),且更易患多发肿瘤(p=0.048),尤其是SDHD基因突变者。突变的存在与更大肿瘤的发生相关(p=0.021)。本研究证实,SDHD基因起始密码子处的错义突变p.Met1Ile是中国HNPGL患者的一个热点突变。我们建议对45岁以下患者进行基因分析,尤其是SDHD基因。